The Asia Pacific Bioinformatics Market should witness market growth of 13.7% CAGR during the forecast period (2022-2028).
The increasing government funding for genomics projects, the rising incidence of cancer and increasing applications of NGS in cancer research, the entry of new players and start-ups into the genomics market, and the growing application areas of genomics are the major factors driving the market's growth.
Moreover, the ongoing trends of the market are expanding government support and the increasing number of genomics studies, reducing sequencing costs, and more genomics applications. The genomics industry is expected to increase at an exponential rate due to important genetic advances and their applications in a variety of fields, including intragenomic phenomena such as epistasis, heterosis, pleiotropy, and other correlations between alleles and locations inside the genome. Bioengineering and synthetic biology applications are expected to play a key role in boosting the growth of genomics.
Technological improvements and a surge in research grants from various institutes are two reasons that are expected to propel the transcriptomics market during the forecasting period. Moreover, the potential for RNAs to be used as diagnostic biomarkers and predictors of treatment response is the key industry trend. Previously, transcriptomics applications were limited to basic gene expression profiling and other research applications like determining the amount of RNA in a biological sample and studying gene expression.
Asia Pacific would see increasing demand for genomics as a result of rising demand for testing in China and genetic sequencing and advancements in bioinformatics. Additionally, there is a growing need for the creation of drugs to treat rare illnesses, and technological developments such as the use of companion diagnostics and next-generation sequencing in this field are driving the industry ahead.
The China market dominated the Asia Pacific Bioinformatics Market by Country in 2021; thereby, achieving a market value of $1.3 Billion by 2028. The Japan market is estimated to grow at a CAGR of 13.1% during (2022-2028). Additionally, The India market would exhibit a CAGR of 14.4% during (2022-2028).
Based on Product & Services, the market is segmented into Knowledge Management Tools, Bioinformatics Platforms and Bioinformatics Services. Based on Sector, the market is segmented into Medical Biotechnology, Plant Biotechnology, Environmental Biotechnology, Animal Biotechnology, Forensic Biotechnology and Others. Based on Application, the market is segmented into Genomics, Chemoinformatics & Drug Design, Transcriptomics, Metabolomics, Proteomics and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Eurofins Scientific SE, Qiagen N.V., Agilent Technologies, Inc., Illumina, Inc., Waters Corporation, PerkinElmer Inc., Genedata AG, Neogenomics laboratories, BGI Group
The increasing government funding for genomics projects, the rising incidence of cancer and increasing applications of NGS in cancer research, the entry of new players and start-ups into the genomics market, and the growing application areas of genomics are the major factors driving the market's growth.
Moreover, the ongoing trends of the market are expanding government support and the increasing number of genomics studies, reducing sequencing costs, and more genomics applications. The genomics industry is expected to increase at an exponential rate due to important genetic advances and their applications in a variety of fields, including intragenomic phenomena such as epistasis, heterosis, pleiotropy, and other correlations between alleles and locations inside the genome. Bioengineering and synthetic biology applications are expected to play a key role in boosting the growth of genomics.
Technological improvements and a surge in research grants from various institutes are two reasons that are expected to propel the transcriptomics market during the forecasting period. Moreover, the potential for RNAs to be used as diagnostic biomarkers and predictors of treatment response is the key industry trend. Previously, transcriptomics applications were limited to basic gene expression profiling and other research applications like determining the amount of RNA in a biological sample and studying gene expression.
Asia Pacific would see increasing demand for genomics as a result of rising demand for testing in China and genetic sequencing and advancements in bioinformatics. Additionally, there is a growing need for the creation of drugs to treat rare illnesses, and technological developments such as the use of companion diagnostics and next-generation sequencing in this field are driving the industry ahead.
The China market dominated the Asia Pacific Bioinformatics Market by Country in 2021; thereby, achieving a market value of $1.3 Billion by 2028. The Japan market is estimated to grow at a CAGR of 13.1% during (2022-2028). Additionally, The India market would exhibit a CAGR of 14.4% during (2022-2028).
Based on Product & Services, the market is segmented into Knowledge Management Tools, Bioinformatics Platforms and Bioinformatics Services. Based on Sector, the market is segmented into Medical Biotechnology, Plant Biotechnology, Environmental Biotechnology, Animal Biotechnology, Forensic Biotechnology and Others. Based on Application, the market is segmented into Genomics, Chemoinformatics & Drug Design, Transcriptomics, Metabolomics, Proteomics and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Eurofins Scientific SE, Qiagen N.V., Agilent Technologies, Inc., Illumina, Inc., Waters Corporation, PerkinElmer Inc., Genedata AG, Neogenomics laboratories, BGI Group
Scope of the Study
By Product & Services
- Knowledge Management Tools
- Bioinformatics Platforms
- Bioinformatics Services
By Sector
- Medical Biotechnology
- Plant Biotechnology
- Environmental Biotechnology
- Animal Biotechnology
- Forensic Biotechnology
- Others
By Application
- Genomics
- Chemoinformatics & Drug Design
- Transcriptomics
- Metabolomics
- Proteomics
- Others
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Thermo Fisher Scientific, Inc.
- Eurofins Scientific SE
- Qiagen N.V.
- Agilent Technologies, Inc.
- Illumina, Inc.
- Waters Corporation
- PerkinElmer Inc.
- Genedata AG
- Neogenomics laboratories
- BGI Group
Unique Offerings
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Bioinformatics Market, by Product & Services
1.4.2 Asia Pacific Bioinformatics Market, by Sector
1.4.3 Asia Pacific Bioinformatics Market, by Application
1.4.4 Asia Pacific Bioinformatics Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Partnerships, Collaborations and Agreements: 2019, Jun - 2022, Oct) Leading Players
Chapter 4. Asia Pacific Bioinformatics Market by Product & Services
4.1 Asia Pacific Knowledge Management Tools Market by Country
4.2 Asia Pacific Bioinformatics Platforms Market by Country
4.3 Asia Pacific Bioinformatics Services Market by Country
Chapter 5. Asia Pacific Bioinformatics Market by Sector
5.1 Asia Pacific Medical Biotechnology Market by Country
5.2 Asia Pacific Plant Biotechnology Market by Country
5.3 Asia Pacific Environmental Biotechnology Market by Country
5.4 Asia Pacific Animal Biotechnology Market by Country
5.5 Asia Pacific Forensic Biotechnology Market by Country
5.6 Asia Pacific Others Market by Country
Chapter 6. Asia Pacific Bioinformatics Market by Application
6.1 Asia Pacific Genomics Market by Country
6.2 Asia Pacific Chemoinformatics & Drug Design Market by Country
6.3 Asia Pacific Transcriptomics Market by Country
6.4 Asia Pacific Metabolomics Market by Country
6.5 Asia Pacific Proteomics Market by Country
6.6 Asia Pacific Others Market by Country
Chapter 7. Asia Pacific Bioinformatics Market by Country
7.1 China Bioinformatics Market
7.1.1 China Bioinformatics Market by Product & Services
7.1.2 China Bioinformatics Market by Sector
7.1.3 China Bioinformatics Market by Application
7.2 Japan Bioinformatics Market
7.2.1 Japan Bioinformatics Market by Product & Services
7.2.2 Japan Bioinformatics Market by Sector
7.2.3 Japan Bioinformatics Market by Application
7.3 India Bioinformatics Market
7.3.1 India Bioinformatics Market by Product & Services
7.3.2 India Bioinformatics Market by Sector
7.3.3 India Bioinformatics Market by Application
7.4 South Korea Bioinformatics Market
7.4.1 South Korea Bioinformatics Market by Product & Services
7.4.2 South Korea Bioinformatics Market by Sector
7.4.3 South Korea Bioinformatics Market by Application
7.5 Singapore Bioinformatics Market
7.5.1 Singapore Bioinformatics Market by Product & Services
7.5.2 Singapore Bioinformatics Market by Sector
7.5.3 Singapore Bioinformatics Market by Application
7.6 Malaysia Bioinformatics Market
7.6.1 Malaysia Bioinformatics Market by Product & Services
7.6.2 Malaysia Bioinformatics Market by Sector
7.6.3 Malaysia Bioinformatics Market by Application
7.7 Rest of Asia Pacific Bioinformatics Market
7.7.1 Rest of Asia Pacific Bioinformatics Market by Product & Services
7.7.2 Rest of Asia Pacific Bioinformatics Market by Sector
7.7.3 Rest of Asia Pacific Bioinformatics Market by Application
Chapter 8. Company Profiles
8.1 Thermo Fisher Scientific, Inc.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.2 Eurofins Scientific SE
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional Analysis
8.2.4 Recent strategies and developments:
8.2.4.1 Acquisition and Mergers:
8.3 Qiagen N.V.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Product Launches and Product Expansions:
8.3.5.2 Acquisition and Mergers:
8.4 Agilent Technologies, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.4.5.2 Acquisition and Mergers:
8.5 Illumina, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.5.5.2 Product Launches and Product Expansions:
8.5.5.3 Acquisition and Mergers:
8.6 PerkinElmer, Inc.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.6.5.2 Product Launches and Product Expansions:
8.7 Waters Corporation
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.8 Neogenomics, Inc.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental Analysis
8.8.4 Research & Development Expenses
8.8.5 Recent strategies and developments:
8.8.5.1 Partnerships, Collaborations, and Agreements:
8.9 BGI Group
8.9.1 Company Overview
8.9.2 Recent strategies and developments:
8.9.2.1 Partnerships, Collaborations, and Agreements:
8.10. Genedata AG
8.10.1 Company Overview
8.10.2 Recent strategies and developments:
8.10.2.1 Partnerships, Collaborations, and Agreements:
Companies Mentioned
- Thermo Fisher Scientific, Inc.
- Eurofins Scientific SE
- Qiagen N.V.
- Agilent Technologies, Inc.
- Illumina, Inc.
- Waters Corporation
- PerkinElmer Inc.
- Genedata AG
- Neogenomics laboratories
- BGI Group
Methodology
LOADING...
